Wierda, W. G., Wang, L., Liu, F. F., Tuazon, S. A., Perna, S. K., Gu, F., Gu, T., Yue, L., Benedetti, M. D., Fang, L., Chen, L., Shadman, M. (2025). Comparison of outcomes for patients (pts) with R/R chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) previously treated with Bruton tyrosine kinase inhibitor (BTKi) and venetoclax from the TRANSCEND CLL 004 study versus a matched cohort of real-world (RW) pts.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7039